Administrations of APF, APS, and APRS significantly decreased relative mRNA gene expression of TNF-α, IL-6, and IL-1β, and increased IL-10 mRNA expression levels, compared with the CK group (p < 0.05). This evidence concerns the gene IL1B and autoimmune polyendocrinopathy.